Latest Evidence Associating Thimerosal-Containing Vaccines with Autism Spectrum & Other Neurodevelopmental Disorders
This presentation will report on the latest scientific/medical evidence from peer-reviewed journal studies associating Thimerosal-containing childhood vaccine administration with an increased risk of autism spectrum and other neurodevelopmental disorders in US children. Detailed information will be provided regarding recent epidemiological methods of analyzing children's medical records in the Centers for Disease Control and Prevention (CDC)'s Vaccine Safety Datalink (VSD) database.
Mark R. Geier, MD, PhD, FACE
Dr. Geier is a MD with a PhD in genetics. He is a Fellow of the American College of Epidemiology. Dr. Geier was in the clinical practice of medicine for more than 30 years. Dr. Geier was a research scientist at the US National Institutes of Health for 10 years, and he has published more than 150 peer-reviewed journal articles, book chapters, and other publications.
David Geier, BS
David Geier is a graduate of UMBC with a degree in biology and a minor in history, and has undertaken graduate studies at the George Washington University. Mr. Geier is currently the vice-president of the non-profit 501(c)3 Institute of Chronic Illnesses, Inc and the non-profit 501(c)3 CoMeD, Inc. Mr. Geier has co-authored more than 100 peer-reviewed scientific/academic studies, book chapters, and other publications, and his research in recent years has focused on the underlying biochemical basis of the causes and treatments of autism spectrum disorder.
